company background image
4123 logo

Center Laboratories TPEX:4123 Stock Report

Last Price

NT$47.45

Market Cap

NT$32.6b

7D

-6.0%

1Y

-0.8%

Updated

13 Jun, 2024

Data

Company Financials

Center Laboratories, Inc.

TPEX:4123 Stock Report

Market Cap: NT$32.6b

4123 Stock Overview

A pharmaceutical company, engages in the manufacturing and trading of pharmaceuticals in Taiwan and internationally.

4123 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends1/6

Center Laboratories, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Center Laboratories
Historical stock prices
Current Share PriceNT$47.45
52 Week HighNT$61.77
52 Week LowNT$40.80
Beta0.82
1 Month Change4.52%
3 Month Change10.74%
1 Year Change-0.84%
3 Year Change-6.10%
5 Year Change3.10%
Change since IPO1,677.67%

Recent News & Updates

Recent updates

We're Not Counting On Center Laboratories (GTSM:4123) To Sustain Its Statutory Profitability

Nov 20
We're Not Counting On Center Laboratories (GTSM:4123) To Sustain Its Statutory Profitability

Shareholder Returns

4123TW PharmaceuticalsTW Market
7D-6.0%0.1%2.5%
1Y-0.8%6.5%26.3%

Return vs Industry: 4123 underperformed the TW Pharmaceuticals industry which returned 6.5% over the past year.

Return vs Market: 4123 underperformed the TW Market which returned 26.3% over the past year.

Price Volatility

Is 4123's price volatile compared to industry and market?
4123 volatility
4123 Average Weekly Movement3.7%
Pharmaceuticals Industry Average Movement4.2%
Market Average Movement4.7%
10% most volatile stocks in TW Market8.5%
10% least volatile stocks in TW Market2.2%

Stable Share Price: 4123 has not had significant price volatility in the past 3 months.

Volatility Over Time: 4123's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1959n/aSu-Chi Wangwww.centerlab.com.tw

Center Laboratories, Inc., a pharmaceutical company, engages in the manufacturing and trading of pharmaceuticals in Taiwan and internationally. It engages in the research and development of small molecule drugs, as well as solutions for neurological and oncological diseases; development of proteins and antibodies; and pharmaceutical CDMO, medical device, software as medical device, nutritional health and agribiotechnology, stem cell and immune cell therapy, and industry investment and venture capital businesses. The company also supplies glass fibre pressure vessels.

Center Laboratories, Inc. Fundamentals Summary

How do Center Laboratories's earnings and revenue compare to its market cap?
4123 fundamental statistics
Market capNT$32.55b
Earnings (TTM)-NT$2.53b
Revenue (TTM)NT$1.42b

22.9x

P/S Ratio

-12.9x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4123 income statement (TTM)
RevenueNT$1.42b
Cost of RevenueNT$780.21m
Gross ProfitNT$642.20m
Other ExpensesNT$3.17b
Earnings-NT$2.53b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-3.68
Gross Margin45.15%
Net Profit Margin-177.73%
Debt/Equity Ratio31.9%

How did 4123 perform over the long term?

See historical performance and comparison

Dividends

3.2%

Current Dividend Yield

-40%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.